---
title: "Specialty Chemicals M&A 2026: Fewer Deals, Stubborn Multiples, and the New Cost of Compliance"
description: Specialty chemicals deal volume fell, but multiples held. PE stayed active, TSCA added diligence friction, and strategics kept reshaping portfolios.
image: https://harborwind.com/hubfs/blog-images/specialty-chemicals-ma-2026-featured-20260802T154524Z-story_metaphor-a8c5eadf282d.webp
---

![HarborWind Partners](https://harborwind.com/hubfs/raw_assets/public/harborwind-partners/images/logo-horizontal.svg)

[![HarborWind Partners](https://harborwind.com/hubfs/raw_assets/public/harborwind-partners/images/logo-horizontal-white.svg?v=hwp16)](https://harborwind.com/)

- [Home](https://harborwind.com)
- [About](https://harborwind.com/about)
- [Team](https://harborwind.com/team)
- [Insights](https://harborwind.com/insights)
- Industry Focus 
    - [Our Investments](https://harborwind.com/portfolio)
    - [Investment Criteria](https://harborwind.com/investment-criteria)
    - [Specialty Chemicals](https://harborwind.com/specialty-chemicals)
    - [Industrials & Industrial Services](https://harborwind.com/niche-manufacturing)
    - [Essential B2B Services](https://harborwind.com/b2b-services)
- [Portfolio](https://harborwind.com/portfolio)

[Start a Conversation](https://harborwind.com/contact)

[![HarborWind Partners](https://harborwind.com/hubfs/raw_assets/public/harborwind-partners/images/logo-horizontal-white.svg?v=hwp16)](https://harborwind.com/) ×

- [Home](https://harborwind.com)
- [About](https://harborwind.com/about)
- [Team](https://harborwind.com/team)
- [Insights](https://harborwind.com/insights)
- Industry Focus 
    - [Our Investments](https://harborwind.com/portfolio)
    - [Investment Criteria](https://harborwind.com/investment-criteria)
    - [Specialty Chemicals](https://harborwind.com/specialty-chemicals)
    - [Industrials & Industrial Services](https://harborwind.com/niche-manufacturing)
    - [Essential B2B Services](https://harborwind.com/b2b-services)
- [Portfolio](https://harborwind.com/portfolio)

Start a Conversation

1. [Home](https://harborwind.com/)
2. Specialty Chemicals M&A 2026: Fewer Deals, Stubborn Multiples, and the New Cost of Compliance

A HarborWind Partners Publication Buy. Build. Compound.

The HarborWind Review

Perspectives on buying, building, and compounding industrial businesses

Printed March 29, 2026 Private Investment Firm · Chicago | Boston harborwind.com/insights

The Firm

We acquire, transform, and hold founder-led businesses for the long term, preserving legacies while compounding value.

What We Invest In

We acquire founder-led businesses generating $2M–$8M EBITDA in the sectors we know.

 Specialty Chemicals  
 Industrials and Industrial Services  
 Essential B2B Services

Offices

Chicago

901 W. Jackson Blvd., Suite 306  
(312) 449-4963

Boston

24 School St, Second Floor  
(617) 701-4963

Contact

 hello@harborwind.com  
 harborwind.com/contact

In This Printing | From The HarborWind Review

# Specialty Chemicals M&A 2026: Fewer Deals, Stubborn Multiples, and the New Cost of Compliance

Specialty chemicals deal volume fell, but multiples held. PE stayed active, TSCA added diligence friction, and strategics kept reshaping portfolios.

By Sean Mahoney  |  March 29, 2026  |  7 Minute Read

Our Thesis

We acquire the businesses that keep industry running. We give them the capital, capabilities, and time to become something greater.

Read This Article Online

Sunday, March 29, 2026 [HarborWind Review](https://harborwind.com/insights) Ideas for enduring industrial businesses

[Chemical Business Owners](https://harborwind.com/insights/chemical-business-owners) [Buy](https://harborwind.com/insights/editorials?section=chemical&chapter=Buy)

# Specialty Chemicals M&A 2026: Fewer Deals, Stubborn Multiples, and the New Cost of Compliance

Specialty chemicals deal volume fell, but multiples held. PE stayed active, TSCA added diligence friction, and strategics kept reshaping portfolios.

 By [Sean Mahoney](https://harborwind.com/insights/author/sean-mahoney) · March 29, 2026 · 7 min read

![A gloved hand tilting a seed-grading sieve as chaff falls away and sound kernels remain](https://harborwind.com/hs-fs/hubfs/blog-images/specialty-chemicals-ma-2026-featured-20260802T154524Z-story_metaphor-a8c5eadf282d.webp?width=1200&height=630&name=specialty-chemicals-ma-2026-featured-20260802T154524Z-story_metaphor-a8c5eadf282d.webp)

A gloved hand tilting a seed-grading sieve as chaff falls away and sound kernels remain

Table of Contents

[← Back to all insights](https://harborwind.com/insights)

Contents

Share

 Copy Link 

[Email](mailto:?subject=%3Cspan+id%3D%22hs_cos_wrapper_name%22+class%3D%22hs_cos_wrapper+hs_cos_wrapper_meta_field+hs_cos_wrapper_type_text%22+style%3D%22%22+data-hs-cos-general-type%3D%22meta_field%22+data-hs-cos-type%3D%22text%22+%3ESpecialty+Chemicals+M%26A+2026%3A+Fewer+Deals%2C+Stubborn+Multiples%2C+and+the+New+Cost+of+Compliance%3C%2Fspan%3E&body=Thought%20you%20might%20find%20this%20interesting:%20https%3A%2F%2Fharborwind.com%2Finsights%2Fspecialty-chemicals-ma-2026)

In the first half of 2025, [only 243 chemical deals were announced, the lowest half-year count since before COVID](https://www.deloitte.com/us/en/insights/industry/chemicals-and-specialty-materials/chemical-industry-outlook.html). You would expect pricing to crack after a number like that. It did not.

The market slowed, but it did not give up its standards. Capstone says [chemicals deal volume fell to 63 announced or completed transactions year to date, down from 87 in the same period of 2024](https://www.capstonepartners.com/insights/article-chemicals-market-update/). In the same update, it says [average purchase multiples still approached 9.0x EV/EBITDA, up from 8.4x a year earlier, and rose to 9.6x when divestitures were excluded](https://www.capstonepartners.com/insights/article-chemicals-market-update/). That is not broad enthusiasm. It is disciplined demand.

Three things explain the mood. Buyers are concentrating on assets with clear margin durability. Private equity is a bigger share of a smaller market. And compliance has stopped being background noise. In 2026, TSCA is not just an operating issue. It is a deal issue, too.

## What does a slower deal market actually mean in specialty chemicals?

A slower market in specialty chemicals means fewer assets are changing hands, not that buyers have lost interest in the category. The volume drop is real, but so is the willingness to pursue specialty businesses with cleaner margins, steadier end markets, and an intelligible compliance story.

### The quiet part of this market is how selective it has become

Deloitte's 2026 outlook says [only 243 deals were made in the first half of 2025](https://www.deloitte.com/us/en/insights/industry/chemicals-and-specialty-materials/chemical-industry-outlook.html), and it pairs that figure with an important caveat: portfolio reevaluations could still set up a later wave of consolidation. Capstone tells the same story from a different angle. Its July 2025 chemicals update says [year-to-date transaction volume fell 27.6% year over year](https://www.capstonepartners.com/insights/article-chemicals-market-update/). That matters because specialty chemicals is not being abandoned. It is being sorted. Buyers still want exposure to formulations, applications, and end markets they can understand. What they do not want is a vague story wrapped around a hard asset base. Founders do not need a perfect narrative. They need one that holds up under diligence.

## Why have multiples stayed firm even as volume fell?

Multiples have stayed firm because buyers are still competing for the small set of specialty assets that look durable. When the market narrows, money does not disappear. It concentrates. Businesses with resilient margins, sticky customers, and clear end-market demand still attract attention, even when the wider deal calendar thins out.

### The buyers who remained kept paying for clarity

Capstone says [average purchase multiples approached 9.0x EV/EBITDA through year to date 2025, compared with 8.4x in the prior year period](https://www.capstonepartners.com/insights/article-chemicals-market-update/). Strip out discounted divestitures and the figure [rises to 9.6x EV/EBITDA](https://www.capstonepartners.com/insights/article-chemicals-market-update/). That is the useful distinction. Weak businesses can still trade at weak prices. Stronger ones have not become cheap simply because the market turned quieter. In plain English, buyers still pay up when the asset feels specific, defendable, and understandable. In specialty chemicals, that usually means a mix of application knowledge, customer entrenchment, and operations that do not fall apart the moment someone opens the diligence room.

> When volume falls and multiples hold, the market is not broad. It is selective.

## What is TSCA doing to specialty chemical deals in 2026?

TSCA is turning compliance into a visible part of valuation, diligence, and timing. It adds cost, paperwork, and uncertainty to deals that already demand technical precision. For buyers, that means deeper questions earlier. For sellers, it means regulatory readiness now sits closer to quality of earnings than many owners would prefer.

### A regulatory file can slow a deal as surely as a weak quarter

The policy detail is not abstract. EPA says [the current risk-evaluation fee is $4,287,000, with the first 50% due 180 days after publication of the final scope document](https://www.epa.gov/tsca-fees/tsca-fees-epa-initiated-risk-evaluations). That puts the initial payment at $2,143,500 before anyone gets to the softer costs of internal time, outside advice, and management attention. For the 2026 timing context, the cleanest accessible summary is that [the next round of TSCA scope and fee activity is expected to land in 2026](https://www.jdsupra.com/legalnews/what-to-expect-under-tsca-in-2026-5809000/). That does not mean every specialty chemicals business is suddenly unfinanceable. It means diligence has another hard edge. A buyer now has to understand product exposure, reporting obligations, and the operating burden attached to them. That is one reason sell-side readiness has become less cosmetic and more procedural, a theme that shows up well beyond chemicals in HarborWind's [founder's guide to selling a manufacturing business](https://harborwind.com/insights/founders-guide-selling-manufacturing-business).

## Who is still buying, and why are portfolios still moving?

Both private equity and strategic buyers are still active, but they are behaving more narrowly than they did in looser markets. Private equity is taking a larger share of a smaller pool of deals, while strategic buyers are reshaping portfolios, exiting weaker lines, and pursuing smaller transactions that sharpen focus rather than simply add scale.

### This is a market of sharper pencils and narrower targets

Capstone says [private equity transactions made up 47.6% of year-to-date sector deals](https://www.capstonepartners.com/insights/article-chemicals-market-update/), while [strategic acquirers still accounted for 52.4% of sector transactions](https://www.capstonepartners.com/insights/article-chemicals-market-update/). C&EN adds needed texture: [private equity deal value in chemicals fell from nearly $20 billion across 278 deals in 2021 to $5.9 billion in 2025](https://cen.acs.org/business/mergers-%26-acquisitions/Private-equity-investors-regroup-chemical/104/web/2026/02), but the publication notes that the decline looked more like a drop in average deal size than a disappearance of activity. BCG says [chemical companies are pursuing smaller, more focused transactions to optimize portfolios, access innovation, and build resilience](https://www.bcg.com/publications/2025/from-megadeals-to-focused-transactions-in-chemicals). Wood Mackenzie makes the seller side plain: [non-core and underperforming assets are still being divested as companies reposition portfolios](https://www.woodmac.com/news/opinion/beyond-commodities-chemical-sector-m-a-insights-for-2026/). Serious buyers still care about the same old things: clear products, durable demand, and a business that knows what it is. That logic runs through HarborWind's own thesis on [why founder-led industrial businesses keep drawing conviction](https://harborwind.com/insights/why-we-buy-founder-led-industrial-businesses).

Buy. Build. Compound.

## Sources

- [Deloitte, 2026 Chemical Industry Outlook](https://www.deloitte.com/us/en/insights/industry/chemicals-and-specialty-materials/chemical-industry-outlook.html)
- [Capstone Partners, Chemicals Market Update - July 2025](https://www.capstonepartners.com/insights/article-chemicals-market-update/)
- [EPA, TSCA Fees for EPA-Initiated Risk Evaluations](https://www.epa.gov/tsca-fees/tsca-fees-epa-initiated-risk-evaluations)
- [JDSupra, What to Expect Under TSCA in 2026](https://www.jdsupra.com/legalnews/what-to-expect-under-tsca-in-2026-5809000/)
- [C&EN, Private Equity Investors Regroup in Chemical Industry](https://cen.acs.org/business/mergers-%26-acquisitions/Private-equity-investors-regroup-chemical/104/web/2026/02)
- [BCG, From Megadeals to Focused Transactions in Chemicals](https://www.bcg.com/publications/2025/from-megadeals-to-focused-transactions-in-chemicals)
- [Wood Mackenzie, Beyond Commodities: Chemical Sector M&A Insights for 2026](https://www.woodmac.com/news/opinion/beyond-commodities-chemical-sector-m-a-insights-for-2026/)
- [HarborWind Partners, The Founder's Guide to Selling a Manufacturing Business](https://harborwind.com/insights/founders-guide-selling-manufacturing-business)
- [HarborWind Partners, Why We Buy Founder-Led Industrial Businesses](https://harborwind.com/insights/why-we-buy-founder-led-industrial-businesses)

## Frequently Asked Questions

### Why are specialty chemicals multiples holding up in a slower market?

Multiples are holding up because buyers are still competing for a limited group of assets with resilient margins, clear end markets, and understandable operations. In a slower market, capital tends to concentrate on businesses that look durable rather than spreading evenly across every asset that comes to market.

### What does the 243-deal figure actually tell buyers and sellers?

The figure signals that the market is selective, not frozen. Fewer deals mean buyers have become choosier about fit, diligence risk, and value. For sellers, it suggests preparation matters more because a weaker asset story does not get the same forgiveness it might have received in a busier market.

### Why does TSCA matter in M&A conversations now?

TSCA matters because regulatory exposure can affect diligence scope, timing, and cost. When buyers see a specialty chemicals company, they are not only looking at margins and customers. They are also asking what reporting, testing, and fee obligations may follow the products and substances inside the business.

### Is private equity still active in specialty chemicals?

Yes. Private equity remains active, but it is behaving more selectively. Capstone says PE made up 47.6% of year-to-date sector deals, while C&EN reports that total deal value has fallen from the 2021 peak. That combination points to continued activity, but with smaller deal sizes and tighter underwriting.

### Why are strategic buyers still reshaping portfolios?

Strategic buyers are still reshaping portfolios because weak demand, overcapacity, and capital discipline have forced clearer choices about where to invest. Instead of chasing size for its own sake, many buyers are pruning non-core assets and using targeted transactions to move toward categories with better margins and stronger long-term fit.

 \`\`\`

## Related reading from HarborWind Insights

- [**Tariffs just made your domestic chemical company more valuable**](https://harborwind.com/insights/tariffs-just-made-your-domestic-chemical-company-more-valuable)
  
  How trade policy repriced a whole class of sellers.
- [**Tariffs change buyer diligence before they change multiples**](https://harborwind.com/insights/tariffs-change-buyer-diligence-before-they-change-multiples)
  
  What buyers look for first when policy shifts.
- [**PFAS reporting is becoming a diligence file**](https://harborwind.com/insights/pfas-reporting-is-becoming-a-diligence-file-not-just-an-ehs-file)
  
  The EPA designation that can surface hidden liabilities.
- [**What HarborWind looks for in a chemical company's data room**](https://harborwind.com/insights/what-we-look-for-in-a-chemical-companys-data-room)
  
  The specific files a disciplined buyer reads first.
- [**AI in specialty chemicals: what actually works**](https://harborwind.com/insights/ai-specialty-chemicals-what-works)
  
  How the technology premium is showing up in multiples.

For Chemical Business Owners

## Considering what comes next for the business?

See how HarborWind approaches succession, stewardship, and the company you have built.

[How We Partner With Owners →](https://harborwind.com/for-business-owners)

The HarborWind Review

## Keep reading with us.

Occasional editorials for owners, operators, and advisors building enduring industrial businesses.

Leave this field blank

Receive the Review

HarborWind editorials only. Unsubscribe at any time.

## HarborWind Partners

\[01\]Firm

- [About](https://harborwind.com/about)
- [Team](https://harborwind.com/team)
- [Portfolio](https://harborwind.com/portfolio)
- [Media Kit](https://harborwind.com/media-kit)

\[02\]Approach

- [Investment Criteria](https://harborwind.com/investment-criteria)
- [For Business Owners](https://harborwind.com/for-business-owners)
- [For Advisors & Intermediaries](https://harborwind.com/for-intermediaries)
- [Selling Your Business](https://harborwind.com/selling-your-business)

\[03\]Sectors

- [Specialty Chemicals](https://harborwind.com/specialty-chemicals)
- [Industrials & Industrial Services](https://harborwind.com/niche-manufacturing)
- [Essential B2B Services](https://harborwind.com/b2b-services)

\[04\]Writing

- [Insights](https://harborwind.com/insights)
- [The Founder's Guide to Selling a Manufacturing Business](https://harborwind.com/insights/founders-guide-selling-manufacturing-business)
- [How Deal-by-Deal Capital Buys Businesses Traditional Private Equity Cannot](https://harborwind.com/insights/why-independent-sponsors-can-buy-businesses-private-equity-cannot)

CHICAGO — 901 W. Jackson Blvd., Suite 306 — [(312) 449-4963](tel:+13124494963)·BOSTON — 24 School St, Second Floor — [(617) 701-4963](tel:+16177014963)

[![HarborWind Partners](https://harborwind.com/hubfs/raw_assets/public/harborwind-partners/images/logo-horizontal-white.svg?v=hwp16)](https://harborwind.com/)

[LinkedIn ↗](https://www.linkedin.com/company/harborwind-partners)

© 2026 HarborWind Partners. All rights reserved.

HarborWind Partners invests its own equity alongside other equity partners to fund acquisitions. Nothing on this website constitutes an offer to sell or solicitation of an offer to purchase any securities. Past performance is not indicative of future results.

HarborWind Partners Buy. Build. Compound.

✕

## Start a Conversation

A member of our team will respond within one business day.

First Name \*

Last Name \*

Email \*

Company Name \*

Inquiry Type Select… Business Owner Intermediary (banker, broker, M&A advisor) Referrer (lawyer, accountant, advisor) Capital Partner Portfolio Sponsor / Portfolio Company Seller Other

What you’re looking for \*

Leave this field blank

Send Message

Thank you.

A member of our team will be in touch within one business day.

✕

## Join the mailing list

Monthly analysis. No sales pitch.

First Name

Last Name

Email \*

Leave this field blank

Subscribe

You’re subscribed.

Look for our next analysis in your inbox.

✕

## Coming soon

We’re putting the finishing touches on this film. Check back soon to watch it.

×

## Introduce Yourself

No deal required. A partner will follow up to open the relationship.

First Name \*

Last Name \*

Firm \*

Email \*

Leave this field blank

Introduce Yourself

Prefer email? Reach us at [hello@harborwind.com](mailto:hello@harborwind.com)

Received.

A partner will follow up to open the relationship.

Something went wrong. Please email [hello@harborwind.com](mailto:hello@harborwind.com) directly.

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://harborwind.com/#organization",
  "@type" : "Organization",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "US",
    "addressLocality" : "Chicago",
    "addressRegion" : "IL",
    "postalCode" : "60607",
    "streetAddress" : "901 W. Jackson Blvd., Suite 306"
  },
  "contactPoint" : [ {
    "@type" : "ContactPoint",
    "areaServed" : "US",
    "contactType" : "Business Development",
    "telephone" : "+16177014963",
    "url" : "https://harborwind.com/contact"
  }, {
    "@type" : "ContactPoint",
    "areaServed" : "US",
    "contactType" : "Business Development",
    "telephone" : "+13124494963",
    "url" : "https://harborwind.com/contact"
  } ],
  "description" : "HarborWind Partners is a buyer and long-term owner of founder-led businesses in specialty chemicals, industrials and industrial services, and essential B2B services.",
  "founder" : [ {
    "@type" : "Person",
    "jobTitle" : "Managing Partner",
    "name" : "Sean Mahoney",
    "sameAs" : "https://www.linkedin.com/in/seanmahoney"
  }, {
    "@type" : "Person",
    "jobTitle" : "Managing Partner",
    "name" : "Rocky Lopez",
    "sameAs" : "https://www.linkedin.com/in/rocky-lopez"
  } ],
  "foundingDate" : "2026",
  "logo" : {
    "@type" : "ImageObject",
    "height" : 120,
    "url" : "//47778732.fs1.hubspotusercontent-na1.net/hubfs/47778732/raw_assets/public/harborwind-partners/images/logo-horizontal.svg",
    "width" : 600
  },
  "name" : "HarborWind Partners",
  "sameAs" : [ "https://www.linkedin.com/company/harborwind-partners", "https://pitchbook.com/profiles/investor/601705-45" ],
  "url" : "https://harborwind.com"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "BreadcrumbList",
  "itemListElement" : [ {
    "@type" : "ListItem",
    "item" : "https://harborwind.com",
    "name" : "Home",
    "position" : 1
  }, {
    "@type" : "ListItem",
    "item" : "https://harborwind.com/insights/specialty-chemicals-ma-2026",
    "name" : "Specialty Chemicals M&amp;A 2026: Fewer Deals, Stubborn Multiples, and the New Cost of Compliance",
    "position" : 2
  } ]
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Sean Mahoney",
    "url" : "https://harborwind.com/insights/author/sean-mahoney"
  },
  "dateModified" : "2026-04-11T02:47:22.232Z",
  "datePublished" : "2026-03-29T04:07:13.000Z",
  "headline" : "Specialty Chemicals M&A 2026: Fewer Deals, Stubborn Multiples, and the New Cost of Compliance",
  "image" : [ "https://harborwind.com/hubfs/blog-images/specialty-chemicals-ma-2026-featured-20260802T154524Z-story_metaphor-a8c5eadf282d.webp" ],
  "mainEntityOfPage" : {
    "@id" : "https://harborwind.com/insights/specialty-chemicals-ma-2026",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://harborwind.com/hubfs/Full%20color@0.75x.png"
    },
    "name" : "HarborWind Partners"
  }
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://harborwind.com/insights/author/sean-mahoney#person",
  "@type" : "Person",
  "description" : "Managing Partner of HarborWind Partners, a buyer and long-term owner of founder-led businesses in specialty chemicals, industrials and industrial services, and essential B2B services. Kellogg MBA. 14 years of combined operating and investing experience.",
  "jobTitle" : "Managing Partner",
  "name" : "Sean Mahoney",
  "sameAs" : [ "https://www.linkedin.com/in/seanmahoney", "https://seanmahoney.com" ],
  "url" : "https://harborwind.com/insights/author/sean-mahoney",
  "worksFor" : {
    "@type" : "Organization",
    "name" : "HarborWind Partners",
    "url" : "https://harborwind.com"
  }
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://harborwind.com/hubfs/blog-images/specialty-chemicals-ma-2026-featured-20260802T154524Z-story_metaphor-a8c5eadf282d.webp#imageObject",
  "@type" : "ImageObject",
  "height" : 630,
  "url" : "https://harborwind.com/hubfs/blog-images/specialty-chemicals-ma-2026-featured-20260802T154524Z-story_metaphor-a8c5eadf282d.webp",
  "width" : 1200
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "FAQPage",
  "mainEntity" : [ {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "Multiples are holding up because buyers are still competing for a limited group of assets with resilient margins, clear end markets, and understandable operations. In a slower market, capital tends to concentrate on businesses that look durable rather than spreading evenly across every asset that comes to market."
    },
    "name" : "Why are specialty chemicals multiples holding up in a slower market?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "The figure signals that the market is selective, not frozen. Fewer deals mean buyers have become choosier about fit, diligence risk, and value. For sellers, it suggests preparation matters more because a weaker asset story does not get the same forgiveness it might have received in a busier market."
    },
    "name" : "What does the 243-deal figure actually tell buyers and sellers?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "TSCA matters because regulatory exposure can affect diligence scope, timing, and cost. When buyers see a specialty chemicals company, they are not only looking at margins and customers. They are also asking what reporting, testing, and fee obligations may follow the products and substances inside the business."
    },
    "name" : "Why does TSCA matter in M&A conversations now?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "Yes. Private equity remains active, but it is behaving more selectively. Capstone says PE made up 47.6% of year-to-date sector deals, while C&EN reports that total deal value has fallen from the 2021 peak. That combination points to continued activity, but with smaller deal sizes and tighter underwriting."
    },
    "name" : "Is private equity still active in specialty chemicals?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "Strategic buyers are still reshaping portfolios because weak demand, overcapacity, and capital discipline have forced clearer choices about where to invest. Instead of chasing size for its own sake, many buyers are pruning non-core assets and using targeted transactions to move toward categories with better margins and stronger long-term fit."
    },
    "name" : "Why are strategic buyers still reshaping portfolios?"
  } ]
}
```